Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?

Published:2024-02-21 Issue:4 Volume:17 Page:309-321
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Boyer Johannes¹,Hoenigl Martin¹²³,Kriegl Lisa¹

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria

2. BioTechMed, Graz, Austria

3. Translational Mycology Working Group, ECMM Excellence Center for Clinical Mycology, Medical University of Graz, Graz, Austria

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2024.2317293

Reference208 articles.

1. WHO. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.

2. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

3. Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

4. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

5. Dark Mold Infections in Solid Organ Transplant Recipients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease;Clinical Microbiology Reviews;2024-06-13